Galovan Scott Michael sold (to issuer) $5.8M of AVNS
Galovan Scott Michael (SVP, Chief Financial Officer) sold (to issuer) 231,717 shares of AVANOS MEDICAL, INC. (AVNS) at $25.00 ($5.79M total) across 2 trades on 2026-07-27.
How this was made
The 30-second read
Why it matters
The newest fact is the CFO’s sale to the issuer at a fixed $25.00/share price and the resulting 0-share direct holdings; it may influence sentiment but does not introduce new business fundamentals.
Market read
Traders may monitor for sentiment effects from insider selling, but the disclosure lacks fundamental catalysts.
What to watch
The filing does not state intent beyond the transaction code, and it provides no linkage to earnings, guidance, or operational changes.
Background
The article is an SEC Form 4 insider transaction disclosure for AVANOS MEDICAL, Inc. (AVNS).
Ticker impact
AVANOS MEDICAL CFO Galovan Scott Michael sold 231,717 shares to the issuer at $25.00/share, leaving 0 shares after the transaction.
Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment around insider selling.
The filing is a Form 4 insider transaction with a specific sale price and post-transaction holdings of 0 shares, but it provides no new operating or guidance information.
Market effects
No sector-level implications; this is company-specific insider transaction disclosure.
None indicated.
None indicated.
Counterpoint
Because the transaction is 'sale to issuer' (often tied to buyback mechanics), it may reflect planned liquidity rather than bearish conviction.
Key entities
- issuerAVANOS MEDICAL, INC.
Company whose CFO insider transaction was disclosed on Form 4.
- insiderGalovan Scott Michael
SVP and Chief Financial Officer who sold shares to the issuer.
